Hexagon Capital Partners’s Precigen PGEN Stock Holding History

Hexagon Capital Partners’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-100	Closed	-$149	–	1253
2025 Q1	$149	Hold	100	–	–	﹤0.01%	1784
2024 Q4	$112	Hold	100	–	–	﹤0.01%	1805
2024 Q3	$95	Hold	100	–	–	﹤0.01%	1540
2024 Q2	$158	Hold	100	–	–	﹤0.01%	1400
2024 Q1	$145	Hold	100	–	–	﹤0.01%	1415
2023 Q4	$134	Hold	100	–	–	﹤0.01%	1373
2023 Q3	$142	Hold	100	–	–	﹤0.01%	1348
2023 Q2	$115	Hold	100	–	–	﹤0.01%	1377
2023 Q1	$106	Hold	100	–	–	﹤0.01%	1390
2022 Q4	$152	Hold	100	–	–	﹤0.01%	1390
2022 Q3	$0	Hold	100	–	–	﹤0.01%	1400
2022 Q2	$0	Hold	100	–	–	﹤0.01%	1228
2022 Q1	$0	Hold	100	–	–	﹤0.01%	967
2021 Q4	$0	Hold	100	–	–	﹤0.01%	884
2021 Q3	$0	Hold	100	–	–	﹤0.01%	879
2021 Q2	$1K	Hold	100	–	–	﹤0.01%	779
2021 Q1	$0	Hold	100	–	–	﹤0.01%	777
2020 Q4	$1K	Hold	100	–	–	﹤0.01%	692
2020 Q3	$0	Buy	+100	New	+$475	﹤0.01%	715

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Hexagon Capital Partners's PGEN Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Precigen (PGEN) in Q2 2025, closing a stake of 100 shares — an estimated $149 sold.

Hexagon Capital Partners first reported a position in PGEN in Q3 2020 and held it in 19 quarters. The position peaked at $1K in Q2 2021. 147 funds tracked by Wall St. Rank hold PGEN as of Q2 2025.

Hexagon Capital Partners reported no remaining Precigen position as of Q2 2025 after selling out during the quarter.
Hexagon Capital Partners sold 100 Precigen shares in Q2 2025, an estimated $149.
Hexagon Capital Partners first reported a position in Precigen in Q3 2020 and held it in 19 quarters.
Hexagon Capital Partners's Precigen position peaked at $1K in Q2 2021.
147 funds tracked by Wall St. Rank held Precigen as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.